Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine
Clinical trial NCT06703190 · TERMINATED
Trial details
- NCT number
- NCT06703190
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-25
- Primary completion
- 2025-06-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.